- Home
- VTVT
as 03-31-2025 3:45pm EST
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | HIGH POINT |
| Market Cap: | 38.8M | IPO Year: | 2015 |
| Target Price: | $35.00 | AVG Volume (30 days): | 47.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.12 - $29.19 | Next Earning Date: | 03-20-2025 |
| Revenue: | $1,017,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest vTv Therapeutics Inc. News
VTVT Breaking Stock News: Dive into VTVT Ticker-Specific Updates for Smart Investing
Zacks
11 days ago
The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics
Associated Press Finance
11 days ago
VTv Therapeutics: Q4 Earnings Snapshot
GlobeNewswire
11 days ago
vTv Therapeutics Announces 2024 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
Clinical Trials Arena
13 days ago
FDA removes hold on vTv’s cadisegliatin clinical programme for diabetes
GuruFocus.com
14 days ago
vTv Therapeutics Soars 43% as FDA Lifts Clinical Hold on Diabetes Drug Trial
GuruFocus.com
14 days ago
FDA Lifts Clinical Hold-vTv Stock Jumps Nearly 28% on Diabetes Drug Progress
MT Newswires
14 days ago
Vtv Therapeutics Says FDA Lifts Clinical Hold on Cadisegliatin Program for Diabetes; Shares Up Pre-Bell
GlobeNewswire
14 days ago
vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes
Compare VTVT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VTVT vTv Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.